112 related articles for article (PubMed ID: 30303204)
1. Development of a selective and highly sensitive fluorescence assay for nucleoside triphosphate diphosphohydrolase1 (NTPDase1, CD39).
Lee SY; Luo X; Namasivayam V; Geiss J; Mirza S; Pelletier J; Stephan H; Sévigny J; Müller CE
Analyst; 2018 Nov; 143(22):5417-5430. PubMed ID: 30303204
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors.
Schäkel L; Schmies CC; Idris RM; Luo X; Lee SY; Lopez V; Mirza S; Vu TH; Pelletier J; Sévigny J; Namasivayam V; Müller CE
Front Pharmacol; 2020; 11():1294. PubMed ID: 33013365
[TBL] [Abstract][Full Text] [Related]
3. High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73.
Kumar M; Lowery R; Kumar V
SLAS Discov; 2020 Mar; 25(3):320-326. PubMed ID: 31868071
[TBL] [Abstract][Full Text] [Related]
4. 2-Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors.
Schäkel L; Mirza S; Pietsch M; Lee SY; Keuler T; Sylvester K; Pelletier J; Sévigny J; Pillaiyar T; Namasivayam V; Gütschow M; Müller CE
Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100300. PubMed ID: 34697820
[TBL] [Abstract][Full Text] [Related]
5. Immunohistological determination of ecto-nucleoside triphosphate diphosphohydrolase1 (NTPDase1) and 5'-nucleotidase in rat hippocampus reveals overlapping distribution.
Bjelobaba I; Stojiljkovic M; Pekovic S; Dacic S; Lavrnja I; Stojkov D; Rakic L; Nedeljkovic N
Cell Mol Neurobiol; 2007 Sep; 27(6):731-43. PubMed ID: 17619139
[TBL] [Abstract][Full Text] [Related]
6. Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine.
Corriden R; Chen Y; Inoue Y; Beldi G; Robson SC; Insel PA; Junger WG
J Biol Chem; 2008 Oct; 283(42):28480-6. PubMed ID: 18713747
[TBL] [Abstract][Full Text] [Related]
7. The expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurons.
Corti F; Olson KE; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2011 May; 337(2):524-32. PubMed ID: 21325440
[TBL] [Abstract][Full Text] [Related]
8. Extracellular ATP inhibits IL-1-induced MMP-1 expression through the action of CD39/nucleotidase triphosphate dephosphorylase-1 on human gingival fibroblasts.
Nemoto E; Gotoh K; Tsuchiya M; Sakisaka Y; Shimauchi H
Int Immunopharmacol; 2013 Nov; 17(3):513-8. PubMed ID: 23941770
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells.
De Giorgi M; Pelikant-Malecka I; Sielicka A; Slominska EM; Giovannoni R; Cinti A; Cerrito MG; Lavitrano M; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):313-8. PubMed ID: 24940685
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity.
Fiene A; Baqi Y; Lecka J; Sévigny J; Müller CE
Analyst; 2015 Jan; 140(1):140-8. PubMed ID: 25372046
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Rat NTPDase1, -2, and -3 ectodomains refolded from bacterial inclusion bodies.
Zebisch M; Sträter N
Biochemistry; 2007 Oct; 46(42):11945-56. PubMed ID: 17910474
[TBL] [Abstract][Full Text] [Related]
12. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain.
Braun N; Sévigny J; Robson SC; Enjyoji K; Guckelberger O; Hammer K; Di Virgilio F; Zimmermann H
Eur J Neurosci; 2000 Dec; 12(12):4357-66. PubMed ID: 11122346
[TBL] [Abstract][Full Text] [Related]
13. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.
Lévesque SA; Lavoie EG; Lecka J; Bigonnesse F; Sévigny J
Br J Pharmacol; 2007 Sep; 152(1):141-50. PubMed ID: 17603550
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 - a promising target for cancer immunotherapy.
Schäkel L; Mirza S; Winzer R; Lopez V; Idris R; Al-Hroub H; Pelletier J; Sévigny J; Tolosa E; Müller CE
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35981785
[TBL] [Abstract][Full Text] [Related]
16. Highly Potent and Selective Ectonucleoside Triphosphate Diphosphohydrolase (ENTPDase1, 2, 3 and 8) Inhibitors Having 2-substituted-7- trifluoromethyl-thiadiazolopyrimidones Scaffold.
Afzal S; Zaib S; Jafari B; Langer P; Lecka J; Sévigny J; Iqbal J
Med Chem; 2020; 16(5):689-702. PubMed ID: 31203806
[TBL] [Abstract][Full Text] [Related]
17. Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes.
Leal DB; Streher CA; Neu TN; Bittencourt FP; Leal CA; da Silva JE; Morsch VM; Schetinger MR
Biochim Biophys Acta; 2005 Jan; 1721(1-3):9-15. PubMed ID: 15652174
[TBL] [Abstract][Full Text] [Related]
18. Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism.
Spatola BN; Lerner AG; Wong C; Dela Cruz T; Welch M; Fung W; Kovalenko M; Losenkova K; Yegutkin GG; Beers C; Corbin J; Soros VB
MAbs; 2020; 12(1):1838036. PubMed ID: 33146056
[TBL] [Abstract][Full Text] [Related]
19. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
20. Identifiability of enzyme kinetic parameters in substrate competition: a case study of CD39/NTPDase1.
McGuinness AN; Tahir A; Sutton NR; Marquis AD
Purinergic Signal; 2024 Jun; 20(3):257-271. PubMed ID: 37165287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
